Notable
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Primary and study completion moved earlier from Nov 1, 2030 to Jun 30, 2029
BioDelivery Sciences InternationalNot specified NCT03720613 Registry history of NCT03720613 on ClinicalTrials.gov (opens the registry)
Updated